Sandra Levy
ARTICLES BY THIS AUTHOR
- 3/22/2020
Generic drug patent cases disrupted by COVID-19
The 30-month stay deadline surrounding generic drug patent disputes is being hampered by courts limiting access and attorneys cutting back on travel. - 3/22/2020
Retailers offer bonuses, expanded benefits as several launch hiring drives
Major retailers are awarding bonuses, expanding employee benefits and launching unprecedented hiring drives as they respond to the COVID-19 crisis. - 3/22/2020
Lupin launches generic Diprolene
Betamethasone dipropionate ointment had a market value of approximately $21 million, according to IQVIA January 2020 data. - 3/19/2020
Pharmacy groups issue policy recommendations to COVID-19 task force
Pharmacy organizations have outlined four policy areas in which pharmacists can support the nation’s COVID-19 response. - 3/19/2020
BD, BioGX submit FDA emergency use authorization requests for COVID-19 diagnostics tests
BD's and BIOGX's new diagnostics could increase capacity of COVID-19 testing by thousands of tests per day. - 3/19/2020
CVS Health opens first COVID-19 testing site in parking lot in Massachusetts
CVS Health's first COVID-19 testing site in Shrewsbury, Mass. will initially focus on first responders and health care workers. - 3/19/2020
Pharma companies ramp up production of hydroxychloroquine to support COVID-19 response
Several pharmaceutical companies are making a commitment to respond to COVID-19 by donating or accelerating the production of hydroxychloroquine. - 3/18/2020
Compounding pharmacies get FDA approval to produce hand sanitizers
Steven Hoffart, owner and operator of Magnolia Pharmacy in Magnolia, Texas, has compounded several orders of pharmaceutical-grade, alcohol-based hand sanitizers for use by first responders. - 3/18/2020
Dr. Reddy's launches pre-filled naloxone syringes
Naloxone hydrochloride injection had a market value of roughly $31 million for the most recent 12 months ended January 2020, according to IQVIA. - 3/18/2020
FIP updates COVID-19 guidelines for pharmacists worldwide
The FIP has issued updated global guidance for pharmacists in community, hospital and clinical biology on COVID-19, replacing its first guidance released last month.
